Pay in 4 interest-free payments of $24.00 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
54(6):352-8
Pirfenidone is an antifibrotic agent that attenuates CCL2 and CCL12 production in fibrocyte cells
Canagliflozin inhibits Na+-dependent 14C-AMG uptake in CHO-hSGLT2 cells
BMS-5 (LIMKi 3) inhibits cofilin-Ser3 phosphorylation in a dose-dependent manner in Nf2ΔEx2 mouse Schwann cells (MSCs) with an IC50 of ~2 µM
Dapagliflozin chin gallate 54(6):352-8Dapagliflozin, also known as BMS 512148, is a drug used to treat type 2 diabetes approved in 2012 by FDA. Dapagliflozin inhibits subtype 2 of the sodium glucose transport proteins (SGLT2) which are responsible for at least 90% of the glucose reabsorption in the kidney. Blocking this transporter mechanism causes blood glucose to be eliminated through the urine. In clinical trials, dapagliflozin lowered HbA1c by 0. 6 versus placebo percentage points
US$ 32.50
US$ 106.50
US$ 2500.00